The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AMGEN INC | COM | 031162100 | 5,997 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
APPLE INC | COM | 037833100 | 8,174 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
FIRST SOLAR INC | COM | 336433107 | 6,847 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
GENTHERM INC | COM | 37253A103 | 1,955 | 47,000 | SH | SOLE | 47,000 | 0 | 0 | ||
HCA HOLDINGS INC | COM | 40412C101 | 7,805 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
NEXPOINT RESIDENTIAL TR INC | COM | 65341D102 | 7,984 | 609,905 | SH | SOLE | 609,905 | 0 | 0 | ||
TAILORED BRANDS INC | COM | 87403A107 | 7,160 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
THERAVANCE BIOPHARMA INC | COM | G8807B106 | 5,170 | 275,000 | SH | SOLE | 275,000 | 0 | 0 |